Tuesday, November 25, 2008 4:08:58 PM
NexMed Amends US Licensing Pact With Warner Chilcott >NEXM
DOW JONES NEWSWIRES
NexMed Inc. (NEXM) said Tuesday it has amended its U.S. licensing agreement with Warner Chilcott Co. (WCRX) regarding NexMed's proprietary topical alprostadil-based cream treatment for erectile dysfunction known as Vitaros.
The East Windsor, N.J., drug developer said the amendment allows Warner Chilcott an additional 45 days, or until Jan. 13, 2009, to review the results of the Oct. 15 meeting with the U.S. Food and Drug Administration, according to a Securities and Exchange Commission filing.
NexMed said the purpose of the Oct. 15 meeting was to gain clarification on the major deficiencies cited by the FDA in its July 21 action letter regarding the new drug application for Vitaros.
The company said that on or before Jan. 13, 2009, Warner Chilcott must decide whether or not it wishes to continue with the development of Vitaros.
NexMed said if Warner Chilcott decides it doesn't wish to continue with Vitaros, then the licensing pact would terminate and all rights would revert back to NexMed.
The company said the pact previously gave Warner Chilcott until Saturday to review such regulatory concerns.
-By Gee L. Lee, Dow Jones Newswires; 202-862-1346
Order free Annual Report for NexMed (USA) Inc.
Visit http://djnewswires.ar.wilink.com/?link=NEXM or call 1-888-301-0513
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/al?rnd=VNf1o8oJFnifzxvjBbgEew%3D%3D. You can use this link on the day this article is published and the following day.
(END) Dow Jones Newswires
11-25-08 1532ET
Copyright (c) 2008 Dow Jones & Company, Inc.
Recent SEEL News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 10:07:04 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:15:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:10:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 12:53:01 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/25/2024 10:09:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:05:35 PM
- Biotech Soars On Material Transfer Agreement • AllPennyStocks.com • 09/24/2024 07:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 01:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/26/2024 04:15:16 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/20/2024 08:01:49 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:02:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/09/2024 08:02:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:01:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:05:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 01:15:52 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/14/2024 08:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:01:36 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2024 08:16:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 01:00:52 PM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM